Theratechnologies Celebrates Strong Q3 Results and Raised Outlook
Company Announcements

Theratechnologies Celebrates Strong Q3 Results and Raised Outlook

Story Highlights

Theratechnologies (TSE:TH) has released an update.

Theratechnologies has reported a robust financial performance for Q3 2024, with an 8% increase in revenue to $22.6 million and a positive net income of $3.1 million. The company also revised its fiscal 2024 revenue guidance to $83-$85 million and increased its Adjusted EBITDA forecast to $17-$19 million, reflecting confidence in continued growth despite a potential temporary supply disruption of their product EGRIFTA SV.

For further insights into TSE:TH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyTheratechnologies unveils study design of PROMISE-US trial of ibalizumab
TheFlyTheratechnologies downgraded to Hold from Buy at JonesResearch
TheFlyDelta reports mixed Q3, Domino’s reports earnings beat: Morning Buzz
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App